Class information for:
Level 1: ANTI TNF ALPHA ANTIBODY INFLIXIMAB//EPIDEMIOL COMPUTAT BIOL//RHEUMATOID CACHEXIA

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
4580 1689 42.4 81%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
389 16325 RHEUMATOID ARTHRITIS//RHEUMATOLOGY//RHEUMATOL

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ANTI TNF ALPHA ANTIBODY INFLIXIMAB Author keyword 37 100% 1% 14
2 EPIDEMIOL COMPUTAT BIOL Address 27 43% 3% 48
3 RHEUMATOID CACHEXIA Author keyword 21 90% 1% 9
4 EPIDEMIOL GENET ATHEROSCLEROSIS GRP SYST IN Address 19 68% 1% 17
5 DUDLEY GRP HOSP NHS TRUST Address 16 52% 1% 22
6 CARDIOVASC PATHOPHYSIOL GENOM UNIT Address 8 27% 1% 25
7 SECT INTERNAL MED ANGIOL ATHEROSCLEROSIS DIS Address 6 80% 0% 4
8 IFIMAV Address 6 16% 2% 36
9 IIS PRINCESA Address 6 33% 1% 15
10 PREVENT CARDIORHEUMA CLIN Address 6 100% 0% 4

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ANTI TNF ALPHA ANTIBODY INFLIXIMAB 37 100% 1% 14 Search ANTI+TNF+ALPHA+ANTIBODY+INFLIXIMAB Search ANTI+TNF+ALPHA+ANTIBODY+INFLIXIMAB
2 RHEUMATOID CACHEXIA 21 90% 1% 9 Search RHEUMATOID+CACHEXIA Search RHEUMATOID+CACHEXIA
3 DEVELOPING POPULATION 2 67% 0% 2 Search DEVELOPING+POPULATION Search DEVELOPING+POPULATION
4 ARTERIAL DYSFUNCTION 1 50% 0% 2 Search ARTERIAL+DYSFUNCTION Search ARTERIAL+DYSFUNCTION
5 ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK 1 50% 0% 2 Search ATHEROSCLEROTIC+CARDIOVASCULAR+DISEASE+RISK Search ATHEROSCLEROTIC+CARDIOVASCULAR+DISEASE+RISK
6 ENDOTHELIAL DEPENDENT FLOW MEDIATED VASODILATATION ED FMD 1 100% 0% 2 Search ENDOTHELIAL+DEPENDENT+FLOW+MEDIATED+VASODILATATION+ED+FMD Search ENDOTHELIAL+DEPENDENT+FLOW+MEDIATED+VASODILATATION+ED+FMD
7 EXTRA ARTICULAR FEATURES 1 100% 0% 2 Search EXTRA+ARTICULAR+FEATURES Search EXTRA+ARTICULAR+FEATURES
8 HEART AFFECTION 1 100% 0% 2 Search HEART+AFFECTION Search HEART+AFFECTION
9 EXTRA ARTICULAR MANIFESTATIONS 1 18% 0% 6 Search EXTRA+ARTICULAR+MANIFESTATIONS Search EXTRA+ARTICULAR+MANIFESTATIONS
10 CARDIOVASCULAR CO MORBIDITY 1 40% 0% 2 Search CARDIOVASCULAR+CO+MORBIDITY Search CARDIOVASCULAR+CO+MORBIDITY

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 EVIDENT CARDIOVASCULAR DISEASE 33 53% 3% 43
2 AORTIC ROOT ABNORMALITIES 30 100% 1% 12
3 ACCELERATED ATHEROGENESIS 25 65% 1% 24
4 DIASTOLIC FUNCTION ABNORMALITIES 18 89% 0% 8
5 FACTOR ALPHA THERAPY 13 22% 3% 51
6 INFLAMMATORY POLYARTHRITIS 11 22% 3% 43
7 PSORIATIC ARTHRITIS PATIENTS 10 61% 1% 11
8 HLA B27 ASSOCIATED DISEASE 8 70% 0% 7
9 NONCARDIAC VASCULAR DISEASE 6 80% 0% 4
10 CHRONIC INFLAMMATORY ARTHRITIDES 5 43% 1% 9

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis 2010 406 97 75%
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis 2015 8 61 59%
Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions 2015 6 113 46%
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives 2011 77 57 82%
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment 2014 13 134 56%
Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE 2011 86 91 68%
Systematic Review and Meta-Analysis: Anti-Tumor Necrosis Factor alpha Therapy and Cardiovascular Events in Rheumatoid Arthritis 2011 86 32 66%
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review 2010 113 48 63%
Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis 2012 33 50 74%
Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review 2011 73 38 74%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 EPIDEMIOL COMPUTAT BIOL 27 43% 2.8% 48
2 EPIDEMIOL GENET ATHEROSCLEROSIS GRP SYST IN 19 68% 1.0% 17
3 DUDLEY GRP HOSP NHS TRUST 16 52% 1.3% 22
4 CARDIOVASC PATHOPHYSIOL GENOM UNIT 8 27% 1.5% 25
5 SECT INTERNAL MED ANGIOL ATHEROSCLEROSIS DIS 6 80% 0.2% 4
6 IFIMAV 6 16% 2.1% 36
7 IIS PRINCESA 6 33% 0.9% 15
8 PREVENT CARDIORHEUMA CLIN 6 100% 0.2% 4
9 IRCCS GALEAZZI ORTHOPED 4 47% 0.4% 7
10 CARDIOVASC ICAR 4 67% 0.2% 4

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000150175 LIBMAN SACKS ENDOCARDITIS//LUPUS MYOCARDITIS//LUPUS CLIN
2 0.0000131673 RHEUMATOID VASCULITIS//RHEUMATOID MYOSITIS//EXTRAARTICULAR MANIFESTATIONS
3 0.0000116275 UNIT MULTIDISCIPLINARY INVEST BIOMED//PSORIATIC NEPHROPATHY//DERMATOL VENEREOL PAEDIAT DERMATOL
4 0.0000108719 COPCORD//RHEUMATIC MUSCULOSKELETAL DISORDERS//COMMUNITY BASED EPIDEMIOL PREVENT TREATMENT RHE
5 0.0000095671 ABATACEPT//TOCILIZUMAB//DISEASE MODIFYING ANTIRHEUMATIC DRUGS
6 0.0000094396 MUSCLE SPECIFIC FORCE//FAK SOZIALE ARBEIT GESUNDHEIT//BEHAVIORAL RISK FACTOR SURVEILLANCE SURVEY
7 0.0000086114 AG LES MARKUS KRANKENHAUS//DESERT ORTHOPED//DISEASE MODIFYING ANTI RHEUMATIC DRUGS DMARD
8 0.0000068891 VICTORIA JOHNSON//VCU PAULEY HEART//VICTORIA JOHNSON S
9 0.0000058614 NEIRID//MOL CELLULAR CARDIOL 7//NEIRID NEUROENDOCRINE INTERACT RHEUMATOL IN
10 0.0000058286 PULMONARY RHEUMATOID NODULE//RHEUMATOID LUNG//RHEUMATOID PLEURITIS